Social anxiety disorder (SAD) has received relatively little attention in neurobiological studies. We sought to identify neuro-anatomical changes associated with successful treatment for the disorder. Fourteen patients (31 years; 57% female) with DSM-IV generalized SAD were imaged before and after 8-weeks of paroxetine treatment on a 1.5 T GE Signa MRI scanner. Symptoms were assessed by a clinician using the Liebowitz Social Anxiety Scale (LSAS). Longitudinal changes in voxel based morphometry (VBM) were determined using the VBM8 Toolbox for SPM8. Symptom severity decreased by 46% following treatment (po 0.001). At week 8, significant gray matter reductions were detected in bilateral caudate and putamen, and right thalamus, and increases in the cerebellum. Gray matter decreases in left thalamus were correlated with clinical response. This is the first study to our knowledge to identify treatment related correlates of symptom improvement for SAD. Replication in larger samples with control groups is needed to confirm these findings, as well as to test their specificity and temporal stability.
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Introduction
Social anxiety disorder (SAD) is among the most commonly occurring psychiatric disorders, with lifetime prevalence of 5-12% (Weissman et al., 1996; Grant et al., 2005; Kessler et al., 2005) . Cardinal features include fear of social situations, particularly those involving exposure to unfamiliar persons, which is associated with avoidance and significant functional impairment (Filho et al., 2010) . SAD also shares a number of clinical features with other anxiety syndromes (Bienvenu et al., 2011; Stein et al., 2011) , and one of the aims of neuroimaging studies has been to identify similarities and differences at the brain level that may guide more precise understanding of etiology, pathophysiology, and mechanisms of treatment response. Well-established treatments for SAD include cognitive-behavioral therapy and selective serotonin reuptake inhibitor (SSRI) medications; however, as many as half of patients do not respond to a course of either treatment (Stein and Stein, 2008) . There is a need for better understanding of mechanisms of treatment, in order to inform treatment selection and improvement.
Most paradigms in imaging studies of SAD to date have compared neural activity in persons with and without the disorder performing tasks related to the core psychopathology, such as viewing of threatening faces (Freitas-Ferrari et al., 2010; Pietrini et al., 2010) , performance anticipation (Lorberbaum et al., 2004; Tillfors et al., 2001) , eye contact (Schneier et al., 2011) , and selfjudgment (Andrews-Hanna et al., 2010; Whitfield-Gabrieli et al., 2011) . Evidence from these studies have implicated hyperactivation of neural circuits serving emotion, particularly the amygdala, striatum, insula, hippocampus, fusiform and parahippocampal region (Bruhl et al., 2014a (Bruhl et al., , 2011 Etkin and Wager, 2007; Freitas-Ferrari et al., 2010) . Disturbances in cingulate and prefrontal circuitry are also reported, but directionality of these results is less consistent (Freitas-Ferrari et al., 2010) . Studies examining structural morphology have been fewer, and with findings less consistent. A pilot study of 13 unmedicated SAD patients found cortical thinning in bilateral fusiform and postcentral, and right hemisphere frontal, parietal and temporal pole regions associated with the disorder (Syal et al., 2012) . A larger study of 46 patients and matched controls, however, found no thinning but increased thickness in the left insula and right anterior cingulate and temporal pole (Bruhl et al., 2014b 
